Biotech · Private company
Technoderma Medicines Inc.
Track this companyFree. Adds Technoderma Medicines Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- TDM-105795 topical vehicle solutionPhase 2 · Alopecia, AndrogeneticClinicalTrials.gov · fetched Nov 12, 2026
- TDM-105795, 0.0025%Phase 2 · Alopecia, AndrogeneticClinicalTrials.gov · fetched Nov 12, 2026
- TDM-105795, 0.02%Phase 2 · Alopecia, AndrogeneticClinicalTrials.gov · fetched Nov 12, 2026
- TDM-180935 topical ointment 1.0%Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- TDM-180935 topical ointment 2.0%Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- TDM-180935 topical vehicle ointment 1Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- TDM-180935 topical vehicle ointment 2Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- TDM-105795Phase 1 · Alopecia, AndrogeneticClinicalTrials.gov · fetched Nov 12, 2026
- TDM-180935Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of TDM-180935 in Atopic Dermatitis PatientsPHASE2 · COMPLETED · started Apr 13, 2024ClinicalTrials.gov NCT06363461 · fetched Nov 12, 2026
- Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic AlopeciaPHASE2 · COMPLETED · started Mar 6, 2023ClinicalTrials.gov NCT05802173 · fetched Nov 12, 2026
- A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male SubjectsPHASE1 · COMPLETED · started Feb 8, 2023ClinicalTrials.gov NCT05525468 · fetched Nov 12, 2026
- A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)PHASE1 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05244980 · fetched Nov 12, 2026
- A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)PHASE1 · COMPLETED · started Apr 27, 2021ClinicalTrials.gov NCT04913519 · fetched Nov 12, 2026